What about the victims rights: Merck's Best Legal Strategy is to Defend Every Vioxx Case

Merck has won half of the Vioxx cases that have gone to trial, which is a "better than expected win-loss tally" according to Ken Frazier. It is in Merck's best interest to continue fighting these cases because a settlement at this point would be costly. Despite what they say, Merck will not fight all 11,000 cases and will likely propose a settlement after the statute of limitations runs out on October 1st. John Simons, CNN 04/26/2006 Read Article: CNN